Skip to main content
OpenTrials
Completed

NCT Number: NCT00436527

Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application

This eight-hour kinetic regression clinical study was conducted to assess the ability of MetroGel® 1% to deliver moisture to facial skin after a single application.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rosacea Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Colorado Springs Research Center

Colorado Springs, Colorado, 80915, United States

About this study

This eight-hour kinetic regression clinical study was conducted to assess the ability of MetroGel® 1% to deliver moisture to facial skin after a single application as measured by the Corneometer CM 825.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of moderate to severe rosacea, defined as the presence of at least moderate erythema with telangiectasia and a minimum of two inflammatory lesions

Exclusion criteria

  • Individuals with active symptoms of allergy (mild active seasonal allergies are acceptable) or atopic dermatitis

Treatment and study plan

Metronidazole gel 1%

Drug

Applied once to a test site on the right or left cheek (as determined by a randomization design)

Other names: MetroGel® 1%

Primary outcomes

  1. Six replicate Corneometer CM 825 measurements

    Time frame: 8 hours

Secondary outcomes

  1. Adverse events

    Time frame: 1 day

Sponsors and collaborators

Lead sponsor

Galderma R&D

Industry

Registry information

Official study title

MetroGel 1% Hydration Study: A Kinetic Regression Study

Important dates

Study start
2006
Primary completion
2006
Study completion
2006
First posted
Feb 19, 2007
Registry last updated
Jul 29, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.